NRX Pharmaceuticals Inc. buy BiotechBee
Start price
10.01.23
/
50%
€1.13
Target price
31.07.24
€2.00
Performance (%)
-49.56%
End price
05.05.23
€0.57
Summary
This prediction ended on 05.05.23 with a price of €0.57. Massive losses of -49.56% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| NRX Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to BiotechBee what are the pros and cons of NRX Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread NRX Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading NRX Pharmaceuticals Inc.
Buy beendet

